Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial

This publication has 20 references indexed in Scilit:

• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation
  New England Journal of Medicine, 2005
• High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability
  European Heart Journal, 2004
• Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
  American Heart Journal, 2004
• Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes
  Circulation, 2003
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Global Burden of Cardiovascular Diseases
  Circulation, 2001
• Ticlopidine and Clopidogrel
  Circulation, 1999
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent
  Cardiovascular Drug Reviews, 1993
• Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: A meta-analysis
  Journal of the American College of Cardiology, 1992